Ben Kelmendi, MD
- 2Articles
- 5.1KReads1
- 2007–2015Active
- 10Collaborators
- 69Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Ben Kelmendi, MD, has contributed to the field of psychiatry with a focus on obsessive-compulsive and related disorders. Publications include studies on the use of riluzole, an antiglutamatergic agent, in treatment-refractory obsessive-compulsive disorder and trichotillomania. Kelmendi's work, published between 2007 and 2015 in Psychiatrist.com, often involved collaboration with researchers such as Christopher Pittenger and Michael H. Bloch.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
